Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Cellular and Molecular Biology Letters

See all formats and pricing
More options …
Volume 16, Issue 2


The mitochondria mediate the induction of NOX1 gene expression by aldosterone in an ATF-1-dependent manner

Yanping Fu / Gang Shi / Yong Wu / Yasuyuki Kawai / Qing Tian / Linlin Yue / Qinjie Xia / Isamu Miyamori / Chunyuan Fan
Published Online: 2011-03-26 | DOI: https://doi.org/10.2478/s11658-011-0002-3


High aldosterone (Ald) levels can induce hypertrophy of vascular smooth muscle cells (VSMCs), which carries high risks of heart failure. A previous study showed that Ald induces hypertrophy of VSMCs by up-regulating NOX1, a catalytic subunit of NADPH oxidase that produces superoxides. However, the precise mechanism remains unknown. Diphenylene iodonium (DPI) is known as an inhibitor of complex I in the mitochondrial respiratory chain, and it was also found to almost completely suppress the induction of NOX1 mRNA and the phosphorylation of activating transcription factor (ATF-1) by PGF2α or PDGF in a rat VSMC cell line. In this study, we found that the Ald-induced phosphorylation of ATF-1 and NOX1 expression was significantly suppressed by DPI. Silencing of ATF-1 gene expression attenuated the induction of NOX1 mRNA expression, and over-expression of ATF-1 restored Ald-induced NOX1 expression. On the basis of this data, we show that the mitochondria mediate aldosterone-induced NOX1 gene expression in an ATF-1-dependent manner.

Keywords: Aldosterone; Mitochondria; ATF-1; NOX1; VSMC

  • [1] Mazak, I., Fiebeler, A., Muller, D.N., Park, J.K., Shagdarsuren, E., Lindschau, C., Dechend, R., Viedt, C., Pilz, B., Haller, H. and Luft, F.C. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation 109 (2004) 2792–2800. http://dx.doi.org/10.1161/01.CIR.0000131860.80444.ABCrossrefGoogle Scholar

  • [2] Pitt, B., Zannad, F., Remme, W.J., Cody, R., Castaigne, A., Perez, A., Palensky, J. and Wittes, J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure, randomized aldactone evaluation study investigators. N. Engl. J. Med. 341 (1999) 709–717. http://dx.doi.org/10.1056/NEJM199909023411001CrossrefGoogle Scholar

  • [3] Zannad, F., Ella, F., Dousset, B., Perez, A. and Pitt, B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the Randomized Aldactone Evaluation Study (RALES), Rales Investigators. Circulation 102 (2000) 2700–2706. Google Scholar

  • [4] Irani, K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ. Res. 87 (2000) 179–183. Google Scholar

  • [5] Griendling, K.K., Sorescu, D. and Ushio-Fukai, M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86 (2000) 449–501. Google Scholar

  • [6] Suh, Y.A., Arnold, R.S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A.B., Griendling, K.K. and Lambeth, J.D. Cell.transformation by the superoxide-generating oxidase Mox1. Nature 401 (1999) 79–82. http://dx.doi.org/10.1038/43459CrossrefGoogle Scholar

  • [7] Lassegue, B., Sorescu, D., Szocs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S.L., Lambeth, J.D. and Griendling, K.K. Griendling, Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 88 (2001) 858–860. http://dx.doi.org/10.1161/hh0901.090299Google Scholar

  • [8] Katsuyama, M., Fan, C., Arakawa, N., Nishinaka, T., Miyagishi, M., Taira, K. and Yabe-Nishimura, C. Essential role of ATF-1 in induction of NOX1, a catalytic subunit of NADPH oxidase: involvement of mitochondrial respiratory chain. Biochem. J. 386 (2005) 255–261. http://dx.doi.org/10.1042/BJ20041180CrossrefGoogle Scholar

  • [9] Matsuno, K., Yamada, H., Iwata, K., Jin, D., Katsuyama, M., Matsuki, M., Takai, S., Yamanish, K., Miyazaki, M., Matsubara, H. and Yabe-Nishimur, C. A Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112 (2005) 2677–2685. http://dx.doi.org/10.1161/CIRCULATIONAHA.105.573709CrossrefGoogle Scholar

  • [10] Nishinaka, T. and Yabe-Nishimura, C. EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress. Free Radic. Biol. Med. 31 (2001) 205–216. http://dx.doi.org/10.1016/S0891-5849(01)00571-8CrossrefGoogle Scholar

  • [11] Miyagishi, M. and Taira, K. U6 promoter-driven siRNAs with four uridine 3’overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol. 20 (2002) 497–500. http://dx.doi.org/10.1038/nbt0502-497CrossrefGoogle Scholar

  • [12] Yokota, T., Sakamoto, N., Enomoto, N., Tanabe, Y., Miyagishi, M., Maekawa, S., Yi, L., Kurosaki, M., Taira, K., Watanabe, M. and Mizusawa, H. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO. Rep. 4 (2003) 602–608. http://dx.doi.org/10.1038/sj.embor.embor840CrossrefGoogle Scholar

  • [13] Li, Y. and Trush, M.A. Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem. Biophys. Res. Commun. 253 (1998) 295–299. http://dx.doi.org/10.1006/bbrc.1998.9729CrossrefGoogle Scholar

  • [14] Montminy, M.R., Sevarino, K.A., Wagner, J.A., Mandel, G.. and Goodman, R.H. Identification of a cyclic-AMP-responsive element within the rat somatostatin gene. Proc. Natl. Acad. Sci. USA 83 (1986) 6682–6686. http://dx.doi.org/10.1073/pnas.83.18.6682CrossrefGoogle Scholar

  • [15] Katsuyama, M., Fan, C. and Yabe-Nishimura, C. NADPH oxidase is involved in prostaglandin F2alpha-induced hypertrophy of vascular smooth muscle cells: induction of NOX1 by PGF2alpha. J. Biol. Chem. 277 (2002) 13438–13442. http://dx.doi.org/10.1074/jbc.M111634200CrossrefGoogle Scholar

  • [16] Katsuyama, M., Cevik, M.O., Arakawa, N., Kakehi, T., Nishinaka, T., Iwata, K., Ibi, M., Matsuno K. and Nishimura, C.Y. Myocyte enhancer factor 2B is involved in the inducible expression of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme. FEBS J. 274 (2007) 5128–5136. http://dx.doi.org/10.1111/j.1742-4658.2007.06034.xCrossrefWeb of ScienceGoogle Scholar

  • [17] Lee, S.B., Bae, I.H., Bae, Y.S. and Um, H.D. Link between mitochondria and NADPH oxidase 1 isozyme for the sustained production of reactive oxygen species and cell death. J. Biol. Chem. 281 (2006) 36228–36235. http://dx.doi.org/10.1074/jbc.M606702200CrossrefGoogle Scholar

  • [18] Young, M. and Funder, J. Mineralocorticoid action and sodium-hydrogen exchange: studies in experimental cardiac fibrosis Endocrinology 144 (2003) 3848–3851. http://dx.doi.org/10.1210/en.2003-0039CrossrefGoogle Scholar

  • [19] Lombes, M., Oblin, M.E., Gasc, J.M., Baulieu, E.E., Farman, N. and Bonvalet, J.P. Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circ. Res. 71 (1992) 503–510. Google Scholar

  • [20] Arriza, J.L., Weinberger, C., Cerelli, G., Glaser, T.M., Handelin B.L., Housman, D.E. and Evans, R.M. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237 (1987) 268–275. http://dx.doi.org/10.1126/science.3037703CrossrefGoogle Scholar

  • [21] Losel, R.M., Feuring, M., Falkenstein, E. and Wehling, M. Nongenomic effects of aldosterone: cellular aspects and clinical implications. Steroids 67 (2002) 493–498. http://dx.doi.org/10.1016/S0039-128X(01)00176-3CrossrefGoogle Scholar

About the article

Published Online: 2011-03-26

Published in Print: 2011-06-01

Citation Information: Cellular and Molecular Biology Letters, Volume 16, Issue 2, Pages 226–235, ISSN (Online) 1689-1392, DOI: https://doi.org/10.2478/s11658-011-0002-3.

Export Citation

© 2011 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Adam P. Harvey, Augusto C. Montezano, Katie Y. Hood, Rheure A. Lopes, Francisco Rios, Graziela Ceravolo, Delyth Graham, and Rhian M. Touyz
Life Sciences, 2017, Volume 179, Page 110
Ralf P. Brandes, Norbert Weissmann, and Katrin Schröder
Antioxidants & Redox Signaling, 2014, Volume 20, Number 6, Page 887

Comments (0)

Please log in or register to comment.
Log in